Michael Cattaneo, PharmD
Vice President, Medical Affairs
Professional Overview
Michael Cattaneo is an accomplished medical affairs executive with over 20 years of experience in the pharmaceutical industry. He currently serves as the Vice President of Medical Affairs at Cingulate Therapeutics, where he oversees the company's medical and scientific strategy, supporting the development and commercialization of innovative therapeutics. Cattaneo is also an Adjunct Assistant Professor at the University of Kansas School of Pharmacy, where he shares his expertise with the next generation of healthcare professionals.
Experience Summary
Current Role
As Vice President of Medical Affairs at Cingulate Therapeutics, Cattaneo is responsible for leading the company's medical and scientific strategy, including the design and execution of clinical studies, the development of medical communication materials, and the engagement with key opinion leaders and healthcare providers. Under his leadership, Cingulate has achieved significant milestones in the advancement of its pipeline, including the successful completion of multiple clinical trials and the expansion of the company's medical affairs team.
Career Progression
Prior to his current role, Cattaneo held various leadership positions at Pfizer Pharmaceuticals, where he demonstrated his expertise in medical affairs, outcomes research, and medical liaison work. As the Senior Director of Medical Affairs, he was instrumental in the successful launch and commercialization of several Pfizer products, contributing to their widespread adoption and positive patient outcomes.
Academic Background
Cattaneo holds a Doctor of Pharmacy (PharmD) degree from the University of Southern California, where he also completed a residency program. His academic achievements and dedication to the field of pharmacy have earned him recognition as an Adjunct Assistant Professor at the University of Kansas School of Pharmacy, where he shares his knowledge and insights with the next generation of healthcare professionals.
Areas of Expertise
- Medical affairs strategy and execution
- Clinical trial design and management
- Medical communication and education
- Key opinion leader engagement
- Outcomes research and data analysis
- Pharmaceutical product launch and commercialization
- Effective leadership and team management
Professional Impact
Throughout his career, Cattaneo has made significant contributions to the pharmaceutical industry. He has led the successful launch and commercialization of several Pfizer products, resulting in improved patient access and outcomes. At Cingulate Therapeutics, Cattaneo has played a pivotal role in advancing the company's pipeline, driving the completion of multiple clinical trials and expanding the medical affairs team to support the development and commercialization of innovative therapies.
Conclusion
With his extensive experience, strong leadership skills, and deep understanding of the pharmaceutical industry, Michael Cattaneo is poised to continue making a positive impact on the healthcare landscape. As he focuses on his current roles at Cingulate Therapeutics and the University of Kansas, Cattaneo remains committed to advancing medical innovation and improving patient care.
